Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury
Ham A, KimM, Kim JY et al. Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury. Kidney Int 2014; 85: 807-823.
Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia
Park SW, Kim M, Kim JY et al. Proximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia. Kidney Int 2012; 82: 878-891.
ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia
Faigle M, Seessle J, Zug S et al. ATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia. PLoS One [online] 2008; 3: E2801.
Neutrophils as sources of extracellular nucleotides: Functional consequences at the vascular interface
Eltzschig HK, Macmanus CF, Colgan SP. Neutrophils as sources of extracellular nucleotides: Functional consequences at the vascular interface. Trends Cardiovasc Med 2008; 18: 103-107.
Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury
Hart ML, Henn M, Kohler D et al. Role of extracellular nucleotide phosphohydrolysis in intestinal ischemia-reperfusion injury. FASEB J 2008; 22: 2784-2797.
Extracellular adenosine production by ecto-50-nucleotidase protects during murine hepatic ischemic preconditioning
Hart ML, Much C, Gorzolla IC et al. Extracellular adenosine production by ecto-50-nucleotidase protects during murine hepatic ischemic preconditioning. Gastroenterology 2008; 135: 1739-1750e3.
Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemiareperfusion injury
Bajwa A, Jo SK, Ye H et al. Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemiareperfusion injury. J Am Soc Nephrol 2010; 21: 955-965.
FTY720 combined with tacrolimus in de novo renal transplantation: 1-year multicenter open-label randomized study
Hoitsma AJ, Woodle ES, Abramowicz D et al. FTY720 combined with tacrolimus in de novo renal transplantation: 1-year, multicenter, open-label randomized study. Nephrol Dial Transplant 2011; 26: 3802-3805.